BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 32973293)

  • 1. T. gondii infection induces IL-1R dependent chronic cachexia and perivascular fibrosis in the liver and skeletal muscle.
    Melchor SJ; Hatter JA; Castillo ÉAL; Saunders CM; Byrnes KA; Sanders I; Abebayehu D; Barker TH; Ewald SE
    Sci Rep; 2020 Sep; 10(1):15724. PubMed ID: 32973293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL-1R Regulates Disease Tolerance and Cachexia in
    Melchor SJ; Saunders CM; Sanders I; Hatter JA; Byrnes KA; Coutermarsh-Ott S; Ewald SE
    J Immunol; 2020 Jun; 204(12):3329-3338. PubMed ID: 32350081
    [No Abstract]   [Full Text] [Related]  

  • 3. The role of IL-1 in adipose browning and muscle wasting in CKD-associated cachexia.
    Cheung WW; Zheng R; Hao S; Wang Z; Gonzalez A; Zhou P; Hoffman HM; Mak RH
    Sci Rep; 2021 Jul; 11(1):15141. PubMed ID: 34302016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic derangements of skeletal muscle from a murine model of glioma cachexia.
    Cui P; Shao W; Huang C; Wu CJ; Jiang B; Lin D
    Skelet Muscle; 2019 Jan; 9(1):3. PubMed ID: 30635036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Leptin Receptor Antagonist Attenuates Adipose Tissue Browning and Muscle Wasting in Infantile Nephropathic Cystinosis-Associated Cachexia.
    Gonzalez A; Cheung WW; Perens EA; Oliveira EA; Gertler A; Mak RH
    Cells; 2021 Jul; 10(8):. PubMed ID: 34440723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular mechanisms and signaling pathways of angiotensin II-induced muscle wasting: potential therapeutic targets for cardiac cachexia.
    Yoshida T; Tabony AM; Galvez S; Mitch WE; Higashi Y; Sukhanov S; Delafontaine P
    Int J Biochem Cell Biol; 2013 Oct; 45(10):2322-32. PubMed ID: 23769949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. JAK/STAT3 pathway inhibition blocks skeletal muscle wasting downstream of IL-6 and in experimental cancer cachexia.
    Bonetto A; Aydogdu T; Jin X; Zhang Z; Zhan R; Puzis L; Koniaris LG; Zimmers TA
    Am J Physiol Endocrinol Metab; 2012 Aug; 303(3):E410-21. PubMed ID: 22669242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth hormone secretagogues prevent dysregulation of skeletal muscle calcium homeostasis in a rat model of cisplatin-induced cachexia.
    Conte E; Camerino GM; Mele A; De Bellis M; Pierno S; Rana F; Fonzino A; Caloiero R; Rizzi L; Bresciani E; Ben Haj Salah K; Fehrentz JA; Martinez J; Giustino A; Mariggiò MA; Coluccia M; Tricarico D; Lograno MD; De Luca A; Torsello A; Conte D; Liantonio A
    J Cachexia Sarcopenia Muscle; 2017 Jun; 8(3):386-404. PubMed ID: 28294567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advances in cancer cachexia: Intersection between affected organs, mediators, and pharmacological interventions.
    Siddiqui JA; Pothuraju R; Jain M; Batra SK; Nasser MW
    Biochim Biophys Acta Rev Cancer; 2020 Apr; 1873(2):188359. PubMed ID: 32222610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of ovarian tumour causes significant loss of muscle and adipose tissue: a novel mouse model for cancer cachexia study.
    Luan Y; Zhang Y; Yu SY; You M; Xu PC; Chung S; Kurita T; Zhu J; Kim SY
    J Cachexia Sarcopenia Muscle; 2022 Apr; 13(2):1289-1301. PubMed ID: 35044098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor-derived IL-6 and trans-signaling among tumor, fat, and muscle mediate pancreatic cancer cachexia.
    Rupert JE; Narasimhan A; Jengelley DHA; Jiang Y; Liu J; Au E; Silverman LM; Sandusky G; Bonetto A; Cao S; Lu X; O'Connell TM; Liu Y; Koniaris LG; Zimmers TA
    J Exp Med; 2021 Jun; 218(6):. PubMed ID: 33851955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Valproic acid attenuates skeletal muscle wasting by inhibiting C/EBPβ-regulated atrogin1 expression in cancer cachexia.
    Sun R; Zhang S; Hu W; Lu X; Lou N; Yang Z; Chen S; Zhang X; Yang H
    Am J Physiol Cell Physiol; 2016 Jul; 311(1):C101-15. PubMed ID: 27122162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth of ovarian cancer xenografts causes loss of muscle and bone mass: a new model for the study of cancer cachexia.
    Pin F; Barreto R; Kitase Y; Mitra S; Erne CE; Novinger LJ; Zimmers TA; Couch ME; Bonewald LF; Bonetto A
    J Cachexia Sarcopenia Muscle; 2018 Aug; 9(4):685-700. PubMed ID: 30009406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The possible role of myostatin in skeletal muscle atrophy and cachexia.
    Jespersen J; Kjaer M; Schjerling P
    Scand J Med Sci Sports; 2006 Apr; 16(2):74-82. PubMed ID: 16533345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cachexia, a Systemic Disease beyond Muscle Atrophy.
    Wyart E; Bindels LB; Mina E; Menga A; Stanga S; Porporato PE
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33202621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exercise as an anti-inflammatory therapy for cancer cachexia: a focus on interleukin-6 regulation.
    Daou HN
    Am J Physiol Regul Integr Comp Physiol; 2020 Feb; 318(2):R296-R310. PubMed ID: 31823669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A standardized herbal combination of Astragalus membranaceus and Paeonia japonica, protects against muscle atrophy in a C26 colon cancer cachexia mouse model.
    Lee SB; Lee JS; Moon SO; Lee HD; Yoon YS; Son CG
    J Ethnopharmacol; 2021 Mar; 267():113470. PubMed ID: 33068652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms to explain wasting of muscle and fat in cancer cachexia.
    Argilés JM; López-Soriano FJ; Busquets S
    Curr Opin Support Palliat Care; 2007 Dec; 1(4):293-8. PubMed ID: 18685378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-17A contributes to skeletal muscle atrophy in lung cancer-induced cachexia via JAK2/STAT3 pathway.
    Ying L; Yao Y; Lv H; Lu G; Zhang Q; Yang Y; Zhou J
    Am J Physiol Cell Physiol; 2022 May; 322(5):C814-C824. PubMed ID: 35319902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pro-cachectic factors link experimental and human chronic kidney disease to skeletal muscle wasting programs.
    Solagna F; Tezze C; Lindenmeyer MT; Lu S; Wu G; Liu S; Zhao Y; Mitchell R; Meyer C; Omairi S; Kilic T; Paolini A; Ritvos O; Pasternack A; Matsakas A; Kylies D; Wiesch JSZ; Turner JE; Wanner N; Nair V; Eichinger F; Menon R; Martin IV; Klinkhammer BM; Hoxha E; Cohen CD; Tharaux PL; Boor P; Ostendorf T; Kretzler M; Sandri M; Kretz O; Puelles VG; Patel K; Huber TB
    J Clin Invest; 2021 Jun; 131(11):. PubMed ID: 34060483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.